Safer Drug Use (ECR552)

Summary of proposal

The proposal consists of 7 components and would commence from 1 July 2022.

Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.

Component 2 would establish one new centre in each capital city. Funding would be ongoing.

Read more

Safer Drug Use (ECR552)

Summary of proposal

The proposal consists of 7 components and would commence from 1 July 2022.

Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.

Component 2 would establish one new centre in each capital city. Funding would be ongoing.

Read more

Safer Drug Use (ECR552)

Summary of proposal

The proposal consists of 7 components and would commence from 1 July 2022.

Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.

Component 2 would establish one new centre in each capital city. Funding would be ongoing.

Read more

Safer Drug Use (ECR552)

Summary of proposal

The proposal consists of 7 components and would commence from 1 July 2022.

Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.

Component 2 would establish one new centre in each capital city. Funding would be ongoing.

Read more

Safer Drug Use (ECR552)

Summary of proposal

The proposal consists of 7 components and would commence from 1 July 2022.

Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.

Component 2 would establish one new centre in each capital city. Funding would be ongoing.

Read more

Safer Drug Use (ECR552)

Summary of proposal

The proposal consists of 7 components and would commence from 1 July 2022.

Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.

Component 2 would establish one new centre in each capital city. Funding would be ongoing.

Read more

Safer Drug Use (ECR552)

Summary of proposal

The proposal consists of 7 components and would commence from 1 July 2022.

Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.

Component 2 would establish one new centre in each capital city. Funding would be ongoing.

Read more

Double the value of corporate penalties for misuse of market power (ECR572)

Summary of proposal

The proposal would double the value of penalties corporations face for the misuse of market power.

The proposal would commence from 1 July 2022.

Read more

Double the value of corporate penalties for misuse of market power (ECR572)

Summary of proposal

The proposal would double the value of penalties corporations face for the misuse of market power.

The proposal would commence from 1 July 2022.

Read more

Double the value of corporate penalties for misuse of market power (ECR572)

Summary of proposal

The proposal would double the value of penalties corporations face for the misuse of market power.

The proposal would commence from 1 July 2022.

Read more